Bayesian Capital Management’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,400
Closed -$271K 597
2021
Q2
$271K Sell
13,400
-38,800
-74% -$795K 0.07% 309
2021
Q1
$1.02M Buy
+52,200
New +$1.09M 0.24% 118
2019
Q1
Sell
-17,134
Closed -$278K 814
2018
Q4
$278K Buy
+17,134
New +$308K 0.06% 431
2018
Q3
Sell
-47,234
Closed -$727K 853
2018
Q2
$727K Sell
47,234
-12,900
-21% -$224K 0.16% 175
2018
Q1
$1.02M Buy
+60,134
New +$969K 0.26% 118
2017
Q4
Sell
-29,400
Closed -$493K 768
2017
Q3
$493K Sell
29,400
-15,600
-35% -$240K 0.12% 268
2017
Q2
$684K Buy
+45,000
New +$639K 0.25% 139
2017
Q1
Sell
-88,900
Closed -$1.06M 750
2016
Q4
$1.06M Buy
+88,900
New +$1.15M 0.26% 114

Other funds holding MNDT

Bayesian Capital Management's MNDT Position: Q3 2021 in Review

Bayesian Capital Management sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2021, closing a stake of 13,400 shares — an estimated $271K sold.

Bayesian Capital Management first reported a position in MNDT in Q4 2016 and held it in 8 quarters. The position peaked at $1.06M in Q4 2016. 274 funds tracked by Wall St. Rank hold MNDT as of Q3 2021.

  • Bayesian Capital Management reported no remaining Mandiant, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 13,400 Mandiant, Inc. Common Stock shares in Q3 2021, an estimated $271K.
  • Bayesian Capital Management first reported a position in Mandiant, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
  • Bayesian Capital Management's Mandiant, Inc. Common Stock position peaked at $1.06M in Q4 2016.
  • 274 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.